Reply to Aitken et al., “Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.